Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2982|27|3|324-332

ISSN： 1350-1925

Source： NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol.27, Iss.3, 2015-03, pp. : 324-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 8, 2015-08 ,pp. : 1057-1068

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging Anabolic Treatments in Osteoporosis

By  

Current Drug Safety, Vol. 6, Iss. 2, 2011-04 ,pp. : 62-74

Bentham Science Publishers

Access to resources Recommend Favorite

Motility/Neurogastroenterology

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S3, 2015-09 ,pp. : 149-154

John Wiley & Sons Inc

Access to resources Recommend Favorite

A ghrelin receptor agonist is an effective colokinetic in rats with diet‐induced constipation

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 610-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 12, 2015-12 ,pp. : 1596-1603

John Wiley & Sons Inc

Access to resources Recommend Favorite